相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phytocystatin CsinCPI-2 Reduces Osteoclastogenesis and Alveolar Bone Loss
N. Da Ponte Leguizamon et al.
JOURNAL OF DENTAL RESEARCH (2022)
Berberine as a promising natural compound for the treatment of periodontal disease: A focus on anti-inflammatory properties
Saeed Mohammadian Haftcheshmeh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Clinical application of mesenchymal stem cells in periodontal regeneration: A systematic review and meta-analysis
Solen Novello et al.
JOURNAL OF PERIODONTAL RESEARCH (2020)
The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
Zhaowei Zhang et al.
BMC PHARMACOLOGY & TOXICOLOGY (2020)
Mesenchymal stem cell -based tissue regeneration therapies for periodontitis
Takehito Ouchi et al.
REGENERATIVE THERAPY (2020)
Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-κB Ligand with a Superior Therapeutic Index
Vagelis Rinotas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions
H. Allard-Chamard et al.
BONE REPORTS (2020)
A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation
Min Jiang et al.
BMC PHARMACOLOGY & TOXICOLOGY (2020)
Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Receptor Activator of Nuclear Factor-κB (RANK) Protein-Protein Interaction by Structure-Based Virtual Screening and Hit Optimization
Min Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension
Nelson B. Watts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Georgia Melagraki et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Adseverin plays a role in osteoclast differentiation and periodontal disease-mediated bone loss
Hongwei Jiang et al.
FASEB JOURNAL (2015)
Denosumab in osteoporosis
Dima L. Diab et al.
EXPERT OPINION ON DRUG SAFETY (2014)
RANKL Expression in Periodontal Disease: Where Does RANKL Come from?
Bin Chen et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab
David L. Lacey et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Targeting osteoclast-osteoblast communication
Xu Cao
NATURE MEDICINE (2011)
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Tomoki Nakashima et al.
NATURE MEDICINE (2011)
Current, new and future treatments of osteoporosis
Pooneh Salari Sharif et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Structure-based development of a receptor activator of nuclear factor-κB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis
Hai Minh Ta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL
Paul J. Kostenuik et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Osteoclast-osteoblast communication
Koichi Matsuo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Inflammation and Bone Loss in Periodontal Disease
David L. Cochran
JOURNAL OF PERIODONTOLOGY (2008)
The bone microenvironment in metastasis; what is special about bone?
Karen M. Bussard et al.
CANCER AND METASTASIS REVIEWS (2008)
Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair
Chan Ho Park et al.
JOURNAL OF PERIODONTOLOGY (2007)
Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system
Sakae Tanaka
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration
Brian T. Feeley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system
S Tanaka et al.
IMMUNOLOGICAL REVIEWS (2005)
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis
N Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases
JJ Body et al.
CANCER (2003)
Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts
T Miyazaki et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
